Experts in discovery and development of antibody therapeutics will discuss and review the state of the art in the field on Wednesday, January 23, 2019. This event aims to expose faculty and staff to therapeutic antibody discovery in an academic setting and foster interest in submission of innovative ideas for antibody targets through an upcoming RFP for Ancora, the collaboration between Vanderbilt and Deerfield. For participants, the event will be an opportunity to gain insight into various aspects of therapeutic antibodies, including how to accelerate antibody discovery through proof-of-concept, and to better understand and leverage resources available on campus and through Ancora.
More information and schedule of events.
